# EDGAR Filing Document

**Accession Number:** 0001845297
**File Stem:** 0001021408-25-004685
**Filing Date:** 2025-8
**Character Count:** 4561
**Document Hash:** e5c64062d5675747f7e947e9202d41e5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001021408-25-004685.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001021408-25-004685

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ABG Innovation Capital Partners III GP Ltd
- **CENTRAL INDEX KEY:** 0001845297

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-20837
- **FILM NUMBER:** 251281400

**BUSINESS ADDRESS:**
- **STREET 1:** SUITE 3902, 39/F, EAST TOWER
- **STREET 2:** CHEUNG KONG CNTR II, 10 HARCOURT ROAD
- **CITY:** CENTRAL, HONG KONG
- **STATE:** K3
- **ZIP:** 000000
- **BUSINESS PHONE:** 852 31219699

**MAIL ADDRESS:**
- **STREET 1:** SUITE 3902, 39/F, EAST TOWER
- **STREET 2:** CHEUNG KONG CNTR II, 10 HARCOURT ROAD
- **CITY:** CENTRAL, HONG KONG
- **STATE:** K3
- **ZIP:** 000000

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001845297

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** ABG Innovation Capital Partners III GP Ltd

**Address:** SUITE 3902, 39/F, EAST TOWER, CENTRAL, HONG KONG, K3 000000

**Telephone number:** 646-809-3771

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-20837

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [ ] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [x] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER             | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                   | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | 06/11/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the Executive Compensation” section of the proxy statement | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | N/A         |                                        0 | NONE                        |  |
| SYNLOGIC INC               | 87166L209 | 12/4/2024      | An advisory vote on the compensation paid to our named executive officers                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | N/A         |                                        0 | NONE                        |  |
| CASTLE BIOSCIENCES INC     | 14843C105 | 05/22/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.                                                                           | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | N/A         |                                        0 | NONE                        |  |

## N-PX: Signature Block

**Reporting Person:** ABG Innovation Capital Partners III GP Ltd

**By (Signature):** Fan Yu

**By (Printed Signature):** Fan Yu

**By (Title):** Director

**Date:** 08/29/2025